Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madhav D Sharma

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cellsDavid H Munn, Madhav D Sharma, Andrew L Mellor
Cancer Research|September 6, 2018
Treg Destabilization and Reprogramming: Implications for Cancer ImmunotherapyDavid H Munn, Madhav D Sharma, Theodore S Johnson
Cancer Immunology, Immunotherapy : CII|May 11, 2017
IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironmentDavid H Munn, Madhav D Sharma, Theodore S Johnson, et al.
Immunity|May 17, 2005
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenaseDavid H Munn, Madhav D Sharma, Babak Baban, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2009
IDO activates regulatory T cells and blocks their conversion into Th17-like T cellsBabak Baban, Phillip R Chandler, Madhav D Sharma, et al.
Blood|April 16, 2009
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodesMadhav D Sharma, De-Yan Hou, Yanjun Liu, et al.
Cancer Research|January 20, 2007
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responsesDe-Yan Hou, Alexander J Muller, Madhav D Sharma, et al.
Immunity|December 15, 2010
Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive miceMadhav D Sharma, De-Yan Hou, Babak Baban, et al.
The Journal of Clinical Investigation|August 22, 2007
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenaseMadhav D Sharma, Babak Baban, Phillip Chandler, et al.
The Journal of Clinical Investigation|July 16, 2004
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodesDavid H Munn, Madhav D Sharma, Deyan Hou, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cellsDavid H Munn, Madhav D Sharma, Andrew L Mellor
Cancer Research|September 6, 2018
Treg Destabilization and Reprogramming: Implications for Cancer ImmunotherapyDavid H Munn, Madhav D Sharma, Theodore S Johnson
Cancer Immunology, Immunotherapy : CII|May 11, 2017
IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironmentDavid H Munn, Madhav D Sharma, Theodore S Johnson, et al.
Immunity|May 17, 2005
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenaseDavid H Munn, Madhav D Sharma, Babak Baban, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2009
IDO activates regulatory T cells and blocks their conversion into Th17-like T cellsBabak Baban, Phillip R Chandler, Madhav D Sharma, et al.
Blood|April 16, 2009
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodesMadhav D Sharma, De-Yan Hou, Yanjun Liu, et al.
Cancer Research|January 20, 2007
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responsesDe-Yan Hou, Alexander J Muller, Madhav D Sharma, et al.
Immunity|December 15, 2010
Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive miceMadhav D Sharma, De-Yan Hou, Babak Baban, et al.
The Journal of Clinical Investigation|August 22, 2007
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenaseMadhav D Sharma, Babak Baban, Phillip Chandler, et al.
The Journal of Clinical Investigation|July 16, 2004
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodesDavid H Munn, Madhav D Sharma, Deyan Hou, et al.
Pageof 2